Global Antisense Oligonucleotides (ASO) Drug Supply, Demand and Key Producers, 2023-2029

Page: 115

Published Date: 02 Sep 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Antisense Oligonucleotides (ASO) Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Antisense oligonucleotide (ASO) drugs are small, synthetic single-stranded nucleic acid polymers that can be used to regulate gene expression through a variety of mechanisms.

This report studies the global Antisense Oligonucleotides (ASO) Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Antisense Oligonucleotides (ASO) Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antisense Oligonucleotides (ASO) Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Antisense Oligonucleotides (ASO) Drug total production and demand, 2018-2029, (K Units)
Global Antisense Oligonucleotides (ASO) Drug total production value, 2018-2029, (USD Million)
Global Antisense Oligonucleotides (ASO) Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Antisense Oligonucleotides (ASO) Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Antisense Oligonucleotides (ASO) Drug domestic production, consumption, key domestic manufacturers and share
Global Antisense Oligonucleotides (ASO) Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Antisense Oligonucleotides (ASO) Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Antisense Oligonucleotides (ASO) Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Antisense Oligonucleotides (ASO) Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ionis, Novartis, Biogen, Akcea, Therapeutics, Sarepta Therapeutics, WAVElife, ProQR and Exicure, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antisense Oligonucleotides (ASO) Drug market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Antisense Oligonucleotides (ASO) Drug Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Antisense Oligonucleotides (ASO) Drug Market, Segmentation by Type
    Fomivirsen
    Spinraza
    Tegsedi
    Waylivra
    Vyondys 53

Global Antisense Oligonucleotides (ASO) Drug Market, Segmentation by Application
    Single Gene Rare Disease
    Protein Deposition Disease
    Chronic Liver Disease
    Others

Companies Profiled:
    Ionis
    Novartis
    Biogen
    Akcea
    Therapeutics
    Sarepta Therapeutics
    WAVElife
    ProQR
    Exicure
    Secarna
    AstraZeneca
    The WhiteOak Group, Inc.
    Dicerna
    Silence
    Arrowhead
    Alnylam

Key Questions Answered
1. How big is the global Antisense Oligonucleotides (ASO) Drug market?
2. What is the demand of the global Antisense Oligonucleotides (ASO) Drug market?
3. What is the year over year growth of the global Antisense Oligonucleotides (ASO) Drug market?
4. What is the production and production value of the global Antisense Oligonucleotides (ASO) Drug market?
5. Who are the key producers in the global Antisense Oligonucleotides (ASO) Drug market?

Table of Contents

1 Supply Summary
    1.1 Antisense Oligonucleotides (ASO) Drug Introduction
    1.2 World Antisense Oligonucleotides (ASO) Drug Supply & Forecast
        1.2.1 World Antisense Oligonucleotides (ASO) Drug Production Value (2018 & 2022 & 2029)
        1.2.2 World Antisense Oligonucleotides (ASO) Drug Production (2018-2029)
        1.2.3 World Antisense Oligonucleotides (ASO) Drug Pricing Trends (2018-2029)
    1.3 World Antisense Oligonucleotides (ASO) Drug Production by Region (Based on Production Site)
        1.3.1 World Antisense Oligonucleotides (ASO) Drug Production Value by Region (2018-2029)
        1.3.2 World Antisense Oligonucleotides (ASO) Drug Production by Region (2018-2029)
        1.3.3 World Antisense Oligonucleotides (ASO) Drug Average Price by Region (2018-2029)
        1.3.4 North America Antisense Oligonucleotides (ASO) Drug Production (2018-2029)
        1.3.5 Europe Antisense Oligonucleotides (ASO) Drug Production (2018-2029)
        1.3.6 China Antisense Oligonucleotides (ASO) Drug Production (2018-2029)
        1.3.7 Japan Antisense Oligonucleotides (ASO) Drug Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Antisense Oligonucleotides (ASO) Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Antisense Oligonucleotides (ASO) Drug Major Market Trends

2 Demand Summary
    2.1 World Antisense Oligonucleotides (ASO) Drug Demand (2018-2029)
    2.2 World Antisense Oligonucleotides (ASO) Drug Consumption by Region
        2.2.1 World Antisense Oligonucleotides (ASO) Drug Consumption by Region (2018-2023)
        2.2.2 World Antisense Oligonucleotides (ASO) Drug Consumption Forecast by Region (2024-2029)
    2.3 United States Antisense Oligonucleotides (ASO) Drug Consumption (2018-2029)
    2.4 China Antisense Oligonucleotides (ASO) Drug Consumption (2018-2029)
    2.5 Europe Antisense Oligonucleotides (ASO) Drug Consumption (2018-2029)
    2.6 Japan Antisense Oligonucleotides (ASO) Drug Consumption (2018-2029)
    2.7 South Korea Antisense Oligonucleotides (ASO) Drug Consumption (2018-2029)
    2.8 ASEAN Antisense Oligonucleotides (ASO) Drug Consumption (2018-2029)
    2.9 India Antisense Oligonucleotides (ASO) Drug Consumption (2018-2029)

3 World Antisense Oligonucleotides (ASO) Drug Manufacturers Competitive Analysis
    3.1 World Antisense Oligonucleotides (ASO) Drug Production Value by Manufacturer (2018-2023)
    3.2 World Antisense Oligonucleotides (ASO) Drug Production by Manufacturer (2018-2023)
    3.3 World Antisense Oligonucleotides (ASO) Drug Average Price by Manufacturer (2018-2023)
    3.4 Antisense Oligonucleotides (ASO) Drug Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Antisense Oligonucleotides (ASO) Drug Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Antisense Oligonucleotides (ASO) Drug in 2022
        3.5.3 Global Concentration Ratios (CR8) for Antisense Oligonucleotides (ASO) Drug in 2022
    3.6 Antisense Oligonucleotides (ASO) Drug Market: Overall Company Footprint Analysis
        3.6.1 Antisense Oligonucleotides (ASO) Drug Market: Region Footprint
        3.6.2 Antisense Oligonucleotides (ASO) Drug Market: Company Product Type Footprint
        3.6.3 Antisense Oligonucleotides (ASO) Drug Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Antisense Oligonucleotides (ASO) Drug Production Value Comparison
        4.1.1 United States VS China: Antisense Oligonucleotides (ASO) Drug Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Antisense Oligonucleotides (ASO) Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Antisense Oligonucleotides (ASO) Drug Production Comparison
        4.2.1 United States VS China: Antisense Oligonucleotides (ASO) Drug Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Antisense Oligonucleotides (ASO) Drug Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Antisense Oligonucleotides (ASO) Drug Consumption Comparison
        4.3.1 United States VS China: Antisense Oligonucleotides (ASO) Drug Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Antisense Oligonucleotides (ASO) Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Antisense Oligonucleotides (ASO) Drug Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Antisense Oligonucleotides (ASO) Drug Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production (2018-2023)
    4.5 China Based Antisense Oligonucleotides (ASO) Drug Manufacturers and Market Share
        4.5.1 China Based Antisense Oligonucleotides (ASO) Drug Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production Value (2018-2023)
        4.5.3 China Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production (2018-2023)
    4.6 Rest of World Based Antisense Oligonucleotides (ASO) Drug Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Antisense Oligonucleotides (ASO) Drug Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production (2018-2023)

5 Market Analysis by Type
    5.1 World Antisense Oligonucleotides (ASO) Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Fomivirsen
        5.2.2 Spinraza
        5.2.3 Tegsedi
        5.2.4 Waylivra
        5.2.5 Vyondys 53
    5.3 Market Segment by Type
        5.3.1 World Antisense Oligonucleotides (ASO) Drug Production by Type (2018-2029)
        5.3.2 World Antisense Oligonucleotides (ASO) Drug Production Value by Type (2018-2029)
        5.3.3 World Antisense Oligonucleotides (ASO) Drug Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Antisense Oligonucleotides (ASO) Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Single Gene Rare Disease
        6.2.2 Protein Deposition Disease
        6.2.3 Chronic Liver Disease
        6.2.4 Others
    6.3 Market Segment by Application
        6.3.1 World Antisense Oligonucleotides (ASO) Drug Production by Application (2018-2029)
        6.3.2 World Antisense Oligonucleotides (ASO) Drug Production Value by Application (2018-2029)
        6.3.3 World Antisense Oligonucleotides (ASO) Drug Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Ionis
        7.1.1 Ionis Details
        7.1.2 Ionis Major Business
        7.1.3 Ionis Antisense Oligonucleotides (ASO) Drug Product and Services
        7.1.4 Ionis Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Ionis Recent Developments/Updates
        7.1.6 Ionis Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis Antisense Oligonucleotides (ASO) Drug Product and Services
        7.2.4 Novartis Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 Biogen
        7.3.1 Biogen Details
        7.3.2 Biogen Major Business
        7.3.3 Biogen Antisense Oligonucleotides (ASO) Drug Product and Services
        7.3.4 Biogen Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Biogen Recent Developments/Updates
        7.3.6 Biogen Competitive Strengths & Weaknesses
    7.4 Akcea
        7.4.1 Akcea Details
        7.4.2 Akcea Major Business
        7.4.3 Akcea Antisense Oligonucleotides (ASO) Drug Product and Services
        7.4.4 Akcea Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Akcea Recent Developments/Updates
        7.4.6 Akcea Competitive Strengths & Weaknesses
    7.5 Therapeutics
        7.5.1 Therapeutics Details
        7.5.2 Therapeutics Major Business
        7.5.3 Therapeutics Antisense Oligonucleotides (ASO) Drug Product and Services
        7.5.4 Therapeutics Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Therapeutics Recent Developments/Updates
        7.5.6 Therapeutics Competitive Strengths & Weaknesses
    7.6 Sarepta Therapeutics
        7.6.1 Sarepta Therapeutics Details
        7.6.2 Sarepta Therapeutics Major Business
        7.6.3 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product and Services
        7.6.4 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Sarepta Therapeutics Recent Developments/Updates
        7.6.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
    7.7 WAVElife
        7.7.1 WAVElife Details
        7.7.2 WAVElife Major Business
        7.7.3 WAVElife Antisense Oligonucleotides (ASO) Drug Product and Services
        7.7.4 WAVElife Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 WAVElife Recent Developments/Updates
        7.7.6 WAVElife Competitive Strengths & Weaknesses
    7.8 ProQR
        7.8.1 ProQR Details
        7.8.2 ProQR Major Business
        7.8.3 ProQR Antisense Oligonucleotides (ASO) Drug Product and Services
        7.8.4 ProQR Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 ProQR Recent Developments/Updates
        7.8.6 ProQR Competitive Strengths & Weaknesses
    7.9 Exicure
        7.9.1 Exicure Details
        7.9.2 Exicure Major Business
        7.9.3 Exicure Antisense Oligonucleotides (ASO) Drug Product and Services
        7.9.4 Exicure Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Exicure Recent Developments/Updates
        7.9.6 Exicure Competitive Strengths & Weaknesses
    7.10 Secarna
        7.10.1 Secarna Details
        7.10.2 Secarna Major Business
        7.10.3 Secarna Antisense Oligonucleotides (ASO) Drug Product and Services
        7.10.4 Secarna Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Secarna Recent Developments/Updates
        7.10.6 Secarna Competitive Strengths & Weaknesses
    7.11 AstraZeneca
        7.11.1 AstraZeneca Details
        7.11.2 AstraZeneca Major Business
        7.11.3 AstraZeneca Antisense Oligonucleotides (ASO) Drug Product and Services
        7.11.4 AstraZeneca Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 AstraZeneca Recent Developments/Updates
        7.11.6 AstraZeneca Competitive Strengths & Weaknesses
    7.12 The WhiteOak Group, Inc.
        7.12.1 The WhiteOak Group, Inc. Details
        7.12.2 The WhiteOak Group, Inc. Major Business
        7.12.3 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product and Services
        7.12.4 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 The WhiteOak Group, Inc. Recent Developments/Updates
        7.12.6 The WhiteOak Group, Inc. Competitive Strengths & Weaknesses
    7.13 Dicerna
        7.13.1 Dicerna Details
        7.13.2 Dicerna Major Business
        7.13.3 Dicerna Antisense Oligonucleotides (ASO) Drug Product and Services
        7.13.4 Dicerna Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Dicerna Recent Developments/Updates
        7.13.6 Dicerna Competitive Strengths & Weaknesses
    7.14 Silence
        7.14.1 Silence Details
        7.14.2 Silence Major Business
        7.14.3 Silence Antisense Oligonucleotides (ASO) Drug Product and Services
        7.14.4 Silence Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Silence Recent Developments/Updates
        7.14.6 Silence Competitive Strengths & Weaknesses
    7.15 Arrowhead
        7.15.1 Arrowhead Details
        7.15.2 Arrowhead Major Business
        7.15.3 Arrowhead Antisense Oligonucleotides (ASO) Drug Product and Services
        7.15.4 Arrowhead Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Arrowhead Recent Developments/Updates
        7.15.6 Arrowhead Competitive Strengths & Weaknesses
    7.16 Alnylam
        7.16.1 Alnylam Details
        7.16.2 Alnylam Major Business
        7.16.3 Alnylam Antisense Oligonucleotides (ASO) Drug Product and Services
        7.16.4 Alnylam Antisense Oligonucleotides (ASO) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Alnylam Recent Developments/Updates
        7.16.6 Alnylam Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Antisense Oligonucleotides (ASO) Drug Industry Chain
    8.2 Antisense Oligonucleotides (ASO) Drug Upstream Analysis
        8.2.1 Antisense Oligonucleotides (ASO) Drug Core Raw Materials
        8.2.2 Main Manufacturers of Antisense Oligonucleotides (ASO) Drug Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Antisense Oligonucleotides (ASO) Drug Production Mode
    8.6 Antisense Oligonucleotides (ASO) Drug Procurement Model
    8.7 Antisense Oligonucleotides (ASO) Drug Industry Sales Model and Sales Channels
        8.7.1 Antisense Oligonucleotides (ASO) Drug Sales Model
        8.7.2 Antisense Oligonucleotides (ASO) Drug Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Antisense Oligonucleotides (ASO) Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Antisense Oligonucleotides (ASO) Drug Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Antisense Oligonucleotides (ASO) Drug Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Antisense Oligonucleotides (ASO) Drug Production Value Market Share by Region (2018-2023)
    Table 5. World Antisense Oligonucleotides (ASO) Drug Production Value Market Share by Region (2024-2029)
    Table 6. World Antisense Oligonucleotides (ASO) Drug Production by Region (2018-2023) & (K Units)
    Table 7. World Antisense Oligonucleotides (ASO) Drug Production by Region (2024-2029) & (K Units)
    Table 8. World Antisense Oligonucleotides (ASO) Drug Production Market Share by Region (2018-2023)
    Table 9. World Antisense Oligonucleotides (ASO) Drug Production Market Share by Region (2024-2029)
    Table 10. World Antisense Oligonucleotides (ASO) Drug Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Antisense Oligonucleotides (ASO) Drug Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Antisense Oligonucleotides (ASO) Drug Major Market Trends
    Table 13. World Antisense Oligonucleotides (ASO) Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Antisense Oligonucleotides (ASO) Drug Consumption by Region (2018-2023) & (K Units)
    Table 15. World Antisense Oligonucleotides (ASO) Drug Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Antisense Oligonucleotides (ASO) Drug Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Antisense Oligonucleotides (ASO) Drug Producers in 2022
    Table 18. World Antisense Oligonucleotides (ASO) Drug Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Antisense Oligonucleotides (ASO) Drug Producers in 2022
    Table 20. World Antisense Oligonucleotides (ASO) Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Antisense Oligonucleotides (ASO) Drug Company Evaluation Quadrant
    Table 22. World Antisense Oligonucleotides (ASO) Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Antisense Oligonucleotides (ASO) Drug Production Site of Key Manufacturer
    Table 24. Antisense Oligonucleotides (ASO) Drug Market: Company Product Type Footprint
    Table 25. Antisense Oligonucleotides (ASO) Drug Market: Company Product Application Footprint
    Table 26. Antisense Oligonucleotides (ASO) Drug Competitive Factors
    Table 27. Antisense Oligonucleotides (ASO) Drug New Entrant and Capacity Expansion Plans
    Table 28. Antisense Oligonucleotides (ASO) Drug Mergers & Acquisitions Activity
    Table 29. United States VS China Antisense Oligonucleotides (ASO) Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Antisense Oligonucleotides (ASO) Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Antisense Oligonucleotides (ASO) Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Antisense Oligonucleotides (ASO) Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production Market Share (2018-2023)
    Table 37. China Based Antisense Oligonucleotides (ASO) Drug Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production Market Share (2018-2023)
    Table 42. Rest of World Based Antisense Oligonucleotides (ASO) Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production Market Share (2018-2023)
    Table 47. World Antisense Oligonucleotides (ASO) Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Antisense Oligonucleotides (ASO) Drug Production by Type (2018-2023) & (K Units)
    Table 49. World Antisense Oligonucleotides (ASO) Drug Production by Type (2024-2029) & (K Units)
    Table 50. World Antisense Oligonucleotides (ASO) Drug Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Antisense Oligonucleotides (ASO) Drug Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Antisense Oligonucleotides (ASO) Drug Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Antisense Oligonucleotides (ASO) Drug Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Antisense Oligonucleotides (ASO) Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Antisense Oligonucleotides (ASO) Drug Production by Application (2018-2023) & (K Units)
    Table 56. World Antisense Oligonucleotides (ASO) Drug Production by Application (2024-2029) & (K Units)
    Table 57. World Antisense Oligonucleotides (ASO) Drug Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Antisense Oligonucleotides (ASO) Drug Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Antisense Oligonucleotides (ASO) Drug Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Antisense Oligonucleotides (ASO) Drug Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Ionis Basic Information, Manufacturing Base and Competitors
    Table 62. Ionis Major Business
    Table 63. Ionis Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 64. Ionis Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Ionis Recent Developments/Updates
    Table 66. Ionis Competitive Strengths & Weaknesses
    Table 67. Novartis Basic Information, Manufacturing Base and Competitors
    Table 68. Novartis Major Business
    Table 69. Novartis Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 70. Novartis Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Novartis Recent Developments/Updates
    Table 72. Novartis Competitive Strengths & Weaknesses
    Table 73. Biogen Basic Information, Manufacturing Base and Competitors
    Table 74. Biogen Major Business
    Table 75. Biogen Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 76. Biogen Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Biogen Recent Developments/Updates
    Table 78. Biogen Competitive Strengths & Weaknesses
    Table 79. Akcea Basic Information, Manufacturing Base and Competitors
    Table 80. Akcea Major Business
    Table 81. Akcea Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 82. Akcea Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Akcea Recent Developments/Updates
    Table 84. Akcea Competitive Strengths & Weaknesses
    Table 85. Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 86. Therapeutics Major Business
    Table 87. Therapeutics Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 88. Therapeutics Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Therapeutics Recent Developments/Updates
    Table 90. Therapeutics Competitive Strengths & Weaknesses
    Table 91. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 92. Sarepta Therapeutics Major Business
    Table 93. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 94. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Sarepta Therapeutics Recent Developments/Updates
    Table 96. Sarepta Therapeutics Competitive Strengths & Weaknesses
    Table 97. WAVElife Basic Information, Manufacturing Base and Competitors
    Table 98. WAVElife Major Business
    Table 99. WAVElife Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 100. WAVElife Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. WAVElife Recent Developments/Updates
    Table 102. WAVElife Competitive Strengths & Weaknesses
    Table 103. ProQR Basic Information, Manufacturing Base and Competitors
    Table 104. ProQR Major Business
    Table 105. ProQR Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 106. ProQR Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. ProQR Recent Developments/Updates
    Table 108. ProQR Competitive Strengths & Weaknesses
    Table 109. Exicure Basic Information, Manufacturing Base and Competitors
    Table 110. Exicure Major Business
    Table 111. Exicure Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 112. Exicure Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Exicure Recent Developments/Updates
    Table 114. Exicure Competitive Strengths & Weaknesses
    Table 115. Secarna Basic Information, Manufacturing Base and Competitors
    Table 116. Secarna Major Business
    Table 117. Secarna Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 118. Secarna Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Secarna Recent Developments/Updates
    Table 120. Secarna Competitive Strengths & Weaknesses
    Table 121. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 122. AstraZeneca Major Business
    Table 123. AstraZeneca Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 124. AstraZeneca Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. AstraZeneca Recent Developments/Updates
    Table 126. AstraZeneca Competitive Strengths & Weaknesses
    Table 127. The WhiteOak Group, Inc. Basic Information, Manufacturing Base and Competitors
    Table 128. The WhiteOak Group, Inc. Major Business
    Table 129. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 130. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. The WhiteOak Group, Inc. Recent Developments/Updates
    Table 132. The WhiteOak Group, Inc. Competitive Strengths & Weaknesses
    Table 133. Dicerna Basic Information, Manufacturing Base and Competitors
    Table 134. Dicerna Major Business
    Table 135. Dicerna Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 136. Dicerna Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Dicerna Recent Developments/Updates
    Table 138. Dicerna Competitive Strengths & Weaknesses
    Table 139. Silence Basic Information, Manufacturing Base and Competitors
    Table 140. Silence Major Business
    Table 141. Silence Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 142. Silence Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. Silence Recent Developments/Updates
    Table 144. Silence Competitive Strengths & Weaknesses
    Table 145. Arrowhead Basic Information, Manufacturing Base and Competitors
    Table 146. Arrowhead Major Business
    Table 147. Arrowhead Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 148. Arrowhead Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Arrowhead Recent Developments/Updates
    Table 150. Alnylam Basic Information, Manufacturing Base and Competitors
    Table 151. Alnylam Major Business
    Table 152. Alnylam Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 153. Alnylam Antisense Oligonucleotides (ASO) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 154. Global Key Players of Antisense Oligonucleotides (ASO) Drug Upstream (Raw Materials)
    Table 155. Antisense Oligonucleotides (ASO) Drug Typical Customers
    Table 156. Antisense Oligonucleotides (ASO) Drug Typical Distributors
List of Figure
    Figure 1. Antisense Oligonucleotides (ASO) Drug Picture
    Figure 2. World Antisense Oligonucleotides (ASO) Drug Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Antisense Oligonucleotides (ASO) Drug Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Antisense Oligonucleotides (ASO) Drug Production (2018-2029) & (K Units)
    Figure 5. World Antisense Oligonucleotides (ASO) Drug Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Antisense Oligonucleotides (ASO) Drug Production Value Market Share by Region (2018-2029)
    Figure 7. World Antisense Oligonucleotides (ASO) Drug Production Market Share by Region (2018-2029)
    Figure 8. North America Antisense Oligonucleotides (ASO) Drug Production (2018-2029) & (K Units)
    Figure 9. Europe Antisense Oligonucleotides (ASO) Drug Production (2018-2029) & (K Units)
    Figure 10. China Antisense Oligonucleotides (ASO) Drug Production (2018-2029) & (K Units)
    Figure 11. Japan Antisense Oligonucleotides (ASO) Drug Production (2018-2029) & (K Units)
    Figure 12. Antisense Oligonucleotides (ASO) Drug Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Antisense Oligonucleotides (ASO) Drug Consumption (2018-2029) & (K Units)
    Figure 15. World Antisense Oligonucleotides (ASO) Drug Consumption Market Share by Region (2018-2029)
    Figure 16. United States Antisense Oligonucleotides (ASO) Drug Consumption (2018-2029) & (K Units)
    Figure 17. China Antisense Oligonucleotides (ASO) Drug Consumption (2018-2029) & (K Units)
    Figure 18. Europe Antisense Oligonucleotides (ASO) Drug Consumption (2018-2029) & (K Units)
    Figure 19. Japan Antisense Oligonucleotides (ASO) Drug Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Antisense Oligonucleotides (ASO) Drug Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Antisense Oligonucleotides (ASO) Drug Consumption (2018-2029) & (K Units)
    Figure 22. India Antisense Oligonucleotides (ASO) Drug Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Antisense Oligonucleotides (ASO) Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Antisense Oligonucleotides (ASO) Drug Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Antisense Oligonucleotides (ASO) Drug Markets in 2022
    Figure 26. United States VS China: Antisense Oligonucleotides (ASO) Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Antisense Oligonucleotides (ASO) Drug Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Antisense Oligonucleotides (ASO) Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production Market Share 2022
    Figure 30. China Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Antisense Oligonucleotides (ASO) Drug Production Market Share 2022
    Figure 32. World Antisense Oligonucleotides (ASO) Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Antisense Oligonucleotides (ASO) Drug Production Value Market Share by Type in 2022
    Figure 34. Fomivirsen
    Figure 35. Spinraza
    Figure 36. Tegsedi
    Figure 37. Waylivra
    Figure 38. Vyondys 53
    Figure 39. World Antisense Oligonucleotides (ASO) Drug Production Market Share by Type (2018-2029)
    Figure 40. World Antisense Oligonucleotides (ASO) Drug Production Value Market Share by Type (2018-2029)
    Figure 41. World Antisense Oligonucleotides (ASO) Drug Average Price by Type (2018-2029) & (US$/Unit)
    Figure 42. World Antisense Oligonucleotides (ASO) Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 43. World Antisense Oligonucleotides (ASO) Drug Production Value Market Share by Application in 2022
    Figure 44. Single Gene Rare Disease
    Figure 45. Protein Deposition Disease
    Figure 46. Chronic Liver Disease
    Figure 47. Others
    Figure 48. World Antisense Oligonucleotides (ASO) Drug Production Market Share by Application (2018-2029)
    Figure 49. World Antisense Oligonucleotides (ASO) Drug Production Value Market Share by Application (2018-2029)
    Figure 50. World Antisense Oligonucleotides (ASO) Drug Average Price by Application (2018-2029) & (US$/Unit)
    Figure 51. Antisense Oligonucleotides (ASO) Drug Industry Chain
    Figure 52. Antisense Oligonucleotides (ASO) Drug Procurement Model
    Figure 53. Antisense Oligonucleotides (ASO) Drug Sales Model
    Figure 54. Antisense Oligonucleotides (ASO) Drug Sales Channels, Direct Sales, and Distribution
    Figure 55. Methodology
    Figure 56. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Ionis
Novartis
Biogen
Akcea
Therapeutics
Sarepta Therapeutics
WAVElife
ProQR
Exicure
Secarna
AstraZeneca
The WhiteOak Group, Inc.
Dicerna
Silence
Arrowhead
Alnylam

Related Reports

Global Antisense Oligonucleotides (ASO) Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Antisense Oligonucleotides (ASO) Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 02 Sep 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Antisense Oligonucleotides (ASO) Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global Antisense Oligonucleotides (ASO) Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Antisense Oligonucleotides (ASO) Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 03 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Antisense Oligonucleotides (ASO) Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Antisense Oligonucleotides (ASO) Drug Supply, Demand and Key Producers, 2024-2030

Global Antisense Oligonucleotides (ASO) Drug Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Pharma & Healthcare

The global Antisense Oligonucleotides (ASO) Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Antisense oligonucleotides (ASO) Drug and siRNA Drug

Antisense Oligonucleotides (ASO) Drug

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>